welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Earlier start of corticosteroids in DMD linked to earlier heart disease onset, study suggests
Researchers say it is important to carefully assess the timing of the start of corticosteroid treatment for Duchenne muscular dystrophy (DMD) in children and its potential association with disease outcomes.
The study, “Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy,” was published in the journal Neuromuscular Disorders.
DMD is an inherited childhood-onset disease characterized by mutations in the DMD gene that provides instructions for making a protein called dystrophin, located primarily in skeletal muscles used for movement and in the heart muscle. These mutations lead to progressive muscle weakness.
rareRelated
-
Considerations for Surgery and Anesthesia in Duchenne PatientsWhen a patient with Duchenne muscular dy...
-
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Gluco...Objective:To evaluate clinical outcomes ...
-
Longitudinal Pulmonary Function Testing Outcome Measures in Duchenne Muscular Dystrophy: Long-term Natural History w...We describe changes in pulmonary functio...
-
The PJ Nicholoff Steroid Protocol for Duchenne and Becker Muscular Dystrophy and Adrenal SuppressionDuchenne muscular dystrophy (DMD or Duch...
-
Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophyObjective: To assess safety and efficac...
-
The impact of deflazacort on puberty in Duchenne muscular dystrophyBackground: The routine use of glucocor...
-
The evaluation of bone age in patients with Duchenne muscular dystrophy on long-term glucocorticoid treatmentLong-term treatment with glucocorticoids...
